Atrantil for Intestinal Bacterial Overgrowth

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Northwestern University

Must not be taking: Atrantil

Disqualifiers: Pregnancy, Breast-feeding, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 4 weeks

40 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What is the purpose of this trial?

This trial is testing Atrantil, a natural supplement made from peppermint, quebracho tree bark, and horse chestnut. It targets patients with Intestinal Methanogenic Overgrowth (IMO), who suffer from excessive methane production in their gut. Atrantil aims to reduce methane gas, which can help relieve symptoms like bloating and constipation.

Research Team

Darren Brenner, MD

Principal Investigator

Northwestern Memorial Hospital/Feinberg School of Medicine

Eligibility Criteria

Inclusion Criteria

Participants must be able to provide informed consent

Participants must be able to attend study visits

Must have a diagnosis of Intestinal Methane Overgrowth based on North American Consensus/American College of Gastroenterology established cutoffs

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants take two capsules of Atrantil three times a day for 28 days

4 weeks

Daily self-administration

Follow-up

Participants are monitored for changes in quality of life and clinical symptoms after treatment

4 weeks

1 visit (in-person) for post-treatment assessment

Treatment Details

Interventions

• Atrantil

Participant Groups

Group I: Experimental: Atrantil (Medical Food) Experimental Treatment 1 Intervention

All participants in the trial will take two capsules of Atrantil three times a day for 28 days.

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials

1,674

Recruited

989,000+